{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:50:18Z","timestamp":1793343018227,"version":"4.5.0"},"reference-count":249,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI050875"],"award-info":[{"award-number":["R01AI050875"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI121700"],"award-info":[{"award-number":["R21AI121700"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ygyno.2021.03.020","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T08:17:45Z","timestamp":1616833065000},"page":"896-912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Non-coding RNAs related to angiogenesis in gynecological cancer"],"prefix":"10.1016","volume":"161","author":[{"given":"Neda","family":"Rahimian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Sadat","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Aslanbeigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Masoud","family":"Mirkhabbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Piroozmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Karim","family":"Shahrzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.03.020_bb0005","series-title":"United States Cancer Statistics: 1999\u20132011 Incidence and Mortality Web-Based Report","author":"U.C.S.W. Group","year":"2014"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0010","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.humpath.2011.11.014","article-title":"Role of cyclin D1 amplification and expression in vulvar carcinomas","volume":"43","author":"Choschzick","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12881","article-title":"Landscape of genomic alterations in cervical carcinomas","volume":"506","author":"Ojesina","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0025","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1038\/ncomms4231","article-title":"Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types","volume":"5","author":"Yang","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0035","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096320","article-title":"Prediction of potential cancer-risk regions based on transcriptome data: towards a comprehensive view","volume":"9","author":"Alisoltani","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0045","doi-asserted-by":"crossref","first-page":"13413","DOI":"10.1038\/srep13413","article-title":"Large-scale RNA-Seq transcriptome analysis of 4043 cancers and 548 Normal tissue controls across 12 TCGA cancer types","volume":"5","author":"Peng","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0050","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/onc.2014.216","article-title":"Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects","volume":"34","author":"Mart\u00ednez","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0055","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/ncomms2693","article-title":"Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer","volume":"4","author":"Mine","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0060","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","article-title":"Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin","volume":"158","author":"Hoadley","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125537","article-title":"Correction: comparative GO: a web application for comparative gene ontology and gene ontology-based gene selection in bacteria","volume":"10","author":"Fruzangohar","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1757-2215-5-22","article-title":"Involvement of autophagy in ovarian cancer: a working hypothesis","volume":"5","author":"Peracchio","year":"2012","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0075","series-title":"Epigenetic Control of Autophagy by microRNAs in Ovarian Cancer","first-page":"343542","volume":"2014","author":"Titone","year":"2014"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0080","series-title":"The Protein Restriction Mimetic Resveratrol is an Autophagy Inducer Stronger Than Amino Acid Starvation in Ovarian Cancer Cells","first-page":"2681","volume":"56","author":"Ferraresi","year":"2017"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0085","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.semcancer.2017.08.003","article-title":"Epigenetics in ovarian cancer","volume":"51","author":"Natanzon","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12943-018-0855-4","article-title":"Epigenetics in ovarian cancer: premise, properties, and perspectives","volume":"17","author":"Yang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13148-018-0602-0","article-title":"Epigenetic therapy for ovarian cancer: promise and progress","volume":"11","author":"Moufarrij","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0105","doi-asserted-by":"crossref","first-page":"a006593","DOI":"10.1101\/cshperspect.a006593","article-title":"The VEGF pathway in cancer and disease: responses, resistance, and the path forward","volume":"2","author":"Kieran","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0110","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0115","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0120","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jbmr.2202","article-title":"Osteoporosis medication use after hip fracture in US patients between 2002 and 2011","volume":"29","author":"Solomon","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0125","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2527\/jas.2012-5724","article-title":"Effects of vaccination on the acute-phase protein response and measures of performance in growing beef calves","volume":"91","author":"Arthington","year":"2013","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0130","doi-asserted-by":"crossref","first-page":"iv280","DOI":"10.1093\/annonc\/mdu337.2","article-title":"Immune correlates and long term follow up of a phase Ia study of MPDL3280A, an engineered PD-L1 antibody, in patients with metastatic renal cell carcinoma (mRCC)","volume":"25","author":"McDermott","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0135","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1634\/theoncologist.2014-0465","article-title":"Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor","volume":"20","author":"Zhao","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0140","series-title":"Worldwide Cancer Data. Global Cancer Statistics for the Most Common Cancers","author":"W.C.R.F.A.I.f.C. Research","year":"2018"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0145","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0150","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.hoc.2012.01.009","article-title":"Targeting angiogenesis in gynecologic cancers","volume":"26","author":"Zand","year":"2012","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2010.12.341","article-title":"Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer","volume":"121","author":"Tapia","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2009.02.025","article-title":"Tyrosine kinase B receptor and BDNF expression in ovarian cancers - effect on cell migration, angiogenesis and clinical outcome","volume":"281","author":"Au","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/PAT.0b013e3283484a3a","article-title":"Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix","volume":"43","author":"Moon","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0170","first-page":"621","article-title":"Proliferative role of BDNF\/TrkB signaling is associated with anoikis resistance in cervical cancer","volume":"40","author":"Yuan","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0175","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(94)90048-5","article-title":"Functions of the neurotrophins during nervous system development: what the knockouts are teaching us","volume":"77","author":"Snider","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pcl.2012.10.002","article-title":"Human milk composition: nutrients and bioactive factors","volume":"60","author":"Ballard","year":"2013","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0185","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00418-015-1360-0","article-title":"Expression of NGF, BDNF and their high-affinity receptors in ovine mammary glands during development and lactation","volume":"144","author":"Colitti","year":"2015","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0190","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1210\/endo.136.10.7664689","article-title":"Expression of neurotrophins and their receptors in the mammalian ovary is developmentally regulated: changes at the time of folliculogenesis","volume":"136","author":"Dissen","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094036","article-title":"The brain-uterus connection: brain derived neurotrophic factor (BDNF) and its receptor (Ntrk2) are conserved in the mammalian uterus","volume":"9","author":"Wessels","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0200","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fphys.2016.00456","article-title":"Nerve growth factor, brain-derived neurotrophic factor and osteocalcin gene relationship in energy regulation, bone homeostasis and reproductive organs analyzed by mRNA quantitative evaluation and linear correlation analysis","volume":"7","author":"Camerino","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0205","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/1471-2407-13-516","article-title":"Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients","volume":"13","author":"Noh","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0210","series-title":"Brain-Derived Neurotrophic Factor (BDNF) -TrKB Signaling Modulates Cancer-endothelial Cells Interaction and Affects the Outcomes of Triple Negative Breast Cancer","first-page":"e0178173","volume":"12","author":"Tsai","year":"2017"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0215","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.3892\/ol.2017.6527","article-title":"Nerve growth factor and its receptors on onset and diagnosis of ovarian cancer","volume":"14","author":"Yu","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0220","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/0008-5472.CAN-07-1183","article-title":"Nerve growth factor is a potential therapeutic target in breast cancer","volume":"68","author":"Adriaenssens","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0225","first-page":"331","article-title":"Transcription levels of nicotinamide nucleotide transhydrogenase and its antisense in breast cancer samples","volume":"21","author":"Saleh Gargari","year":"2019","journal-title":"Cell J."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0230","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0235","first-page":"9","article-title":"Intratumor microvessel density as a prognostic factor in cancer","volume":"147","author":"Weidner","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0240","series-title":"Biology of Endothelial Cells","first-page":"412","article-title":"Angiogenesis","author":"Folkman","year":"1984"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0245","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fonc.2018.00248","article-title":"Unraveling the role of angiogenesis in cancer ecosystems","volume":"8","author":"Zuazo-Gaztelu","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0250","first-page":"334","article-title":"First steps of tumor-related angiogenesis","volume":"65","author":"Paku","year":"1991","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PPO.0000000000000138","article-title":"The contribution of angiogenesis to the process of metastasis","volume":"21","author":"Bielenberg","year":"2015","journal-title":"Cancer J."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0260","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"Macfarlane","year":"2010","journal-title":"Curr. Genom."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0265","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0270","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature07242","article-title":"The impact of microRNAs on protein output","volume":"455","author":"Baek","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020363","article-title":"Human MicroRNA targets","volume":"2","author":"John","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0280","first-page":"101","article-title":"Prediction of human microRNA targets","volume":"342","author":"John","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0285","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.molcel.2004.05.027","article-title":"Computational identification of plant microRNAs and their targets, including a stress-induced miRNA","volume":"14","author":"Jones-Rhoades","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0290","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0300","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of mammalian microRNA targets","volume":"115","author":"Lewis","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0305","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cell.2006.07.031","article-title":"A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes","volume":"126","author":"Miranda","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0310","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/ng1798","article-title":"microRNA target predictions in animals","volume":"38 Suppl","author":"Rajewsky","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0315","doi-asserted-by":"crossref","first-page":"178075","DOI":"10.1155\/2014\/178075","article-title":"MicroRNA in cervical cancer: oncomiRs and tumor suppressor miRs in diagnosis and treatment","volume":"2014","author":"Banno","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0320","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13277-015-3806-3","article-title":"C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer","volume":"37","author":"Zhang","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0325","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/17441692.2013.850524","article-title":"Cervical cancer and the global health agenda: insights from multiple policy-analysis frameworks","volume":"8","author":"Parkhurst","year":"2013","journal-title":"Glob. Publ. Health"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0330","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.7314\/APJCP.2015.16.17.7401","article-title":"Review of the cervical cancer burden and population-based cervical cancer screening in China","volume":"16","author":"Di","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0335","doi-asserted-by":"crossref","first-page":"25266","DOI":"10.18632\/oncotarget.4457","article-title":"MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3","volume":"6","author":"Fan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0340","article-title":"Down-regulation of miR-129-5p inhibits growth and induces apoptosis in laryngeal squamous cell carcinoma by targeting APC","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0345","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/path.2901","article-title":"Zic2 synergistically enhances hedgehog signalling through nuclear retention of Gli1 in cervical cancer cells","volume":"225","author":"Chan","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0350","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1038\/cddis.2013.193","article-title":"miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer","volume":"4","author":"Karaayvaz","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0355","doi-asserted-by":"crossref","first-page":"34423","DOI":"10.18632\/oncotarget.5406","article-title":"Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0360","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.18632\/oncotarget.3254","article-title":"A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ","volume":"6","author":"Tan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0365","doi-asserted-by":"crossref","first-page":"28257","DOI":"10.18632\/oncotarget.4960","article-title":"Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2","volume":"6","author":"Inaguma","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0370","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1158\/1078-0432.CCR-12-0037","article-title":"The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer","volume":"18","author":"Marchini","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0375","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1080\/15384047.2018.1491497","article-title":"Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer","volume":"19","author":"Wang","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0380","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1002\/ijc.25923","article-title":"MiR-9 downregulates CDX2 expression in gastric cancer cells","volume":"129","author":"Rotkrua","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0385","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-4598-7-35","article-title":"Potential role of miR-9 and miR-223 in recurrent ovarian cancer","volume":"7","author":"Laios","year":"2008","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0390","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/hum.2018.059","article-title":"Inhibition of microRNA-9-5p protects against cardiac remodeling following myocardial infarction in mice","volume":"30","author":"Xiao","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0395","doi-asserted-by":"crossref","first-page":"C80","DOI":"10.1152\/ajpcell.00232.2016","article-title":"MiR-9-5p promotes MSC migration by activating \u03b2-catenin signaling pathway","volume":"313","author":"Li","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2019.02.003","article-title":"MicroRNA-9-5p promotes angiogenesis but inhibits apoptosis and inflammation of high glucose-induced injury in human umbilical vascular endothelial cells by targeting CXCR4","volume":"130","author":"Yi","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0405","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12885-016-2430-y","article-title":"Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones","volume":"16","author":"Vojtechova","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0410","first-page":"7314","article-title":"MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5","volume":"23","author":"Wei","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0415","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1158\/1078-0432.CCR-07-1231","article-title":"Altered MicroRNA expression in cervical carcinomas","volume":"14","author":"Lee","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0420","first-page":"121","article-title":"Quantitative analysis of the relationship between microRNA-124a, -34b and -203 gene methylation and cervical oncogenesis","volume":"4","author":"Botezatu","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0425","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/epi.23605","article-title":"Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis","volume":"8","author":"Wilting","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0430","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1742-4658.2010.07997.x","article-title":"microRNA-203 suppresses bladder cancer development by repressing bcl-w expression","volume":"278","author":"Bo","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0435","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1756-9966-31-58","article-title":"MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells","volume":"31","author":"Wang","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0440","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4161\/cc.10.7.15180","article-title":"MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines","volume":"10","author":"Viticchi\u00e8","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0445","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/carcin\/bgp250","article-title":"miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma","volume":"31","author":"Furuta","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0450","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000350125","article-title":"miR-203 suppresses tumor growth and angiogenesis by targeting VEGFA in cervical cancer","volume":"32","author":"Zhu","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0455","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOH.0b013e328345a180","article-title":"MicroRNA-mediated regulation of the angiogenic switch","volume":"18","author":"Anand","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0460","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1038\/onc.2013.335","article-title":"Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talks confers angiogenesis of cervical cancer","volume":"33","author":"Huang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0465","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/jnci\/87.16.1237","article-title":"Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia","volume":"87","author":"Guidi","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0470","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","article-title":"The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis","volume":"15","author":"Wang","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0475","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","article-title":"miR-126 regulates angiogenic signaling and vascular integrity","volume":"15","author":"Fish","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0480","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.peptides.2005.02.017","article-title":"The role of adrenomedullin in angiogenesis","volume":"26","author":"Ribatti","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0485","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11010-011-0723-7","article-title":"Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2","volume":"351","author":"Zhu","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0490","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1073\/pnas.0707493105","article-title":"MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1","volume":"105","author":"Harris","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0495","doi-asserted-by":"crossref","first-page":"18626","DOI":"10.1002\/jcp.28501","article-title":"Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway","volume":"234","author":"Zhang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0510","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.18632\/oncotarget.14738","article-title":"Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0525","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1038\/onc.2013.317","article-title":"Crosstalk-induced loss of miR-126 promotes angiogenesis","volume":"33","author":"de Giorgio","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0530","doi-asserted-by":"crossref","DOI":"10.1177\/1470320316663327","article-title":"miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan","volume":"17","author":"Yue","year":"2016","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067846","article-title":"MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer","volume":"8","author":"How","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0540","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1016\/j.febslet.2014.07.020","article-title":"miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer","volume":"588","author":"Li","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0545","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canep.2013.12.005","article-title":"MicroRNA-451 suppresses tumor cell growth by down-regulating IL6R gene expression","volume":"38","author":"Liu","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0550","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0555","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2008.19.1684","article-title":"Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup","volume":"27","author":"Bookman","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0560","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3892\/mmr.2014.3066","article-title":"Positive Nin one binding protein expression predicts poor outcome in prostate cancer","volume":"11","author":"Chen","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0565","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13046-017-0648-4","article-title":"PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3\u03b2\/\u03b2-catenin\/cyclin D1 signaling pathway in ER-negative breast cancer","volume":"36","author":"Gao","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0570","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0575","first-page":"149","article-title":"Upregulated microRNA-224 promotes ovarian cancer cell proliferation by targeting KLLN, In vitro cellular & developmental biology","volume":"53","author":"Hu","year":"2017","journal-title":"Animal"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0580","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijbiomac.2018.05.151","article-title":"Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling","volume":"117","author":"Jin","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0585","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/CAD.0000000000000107","article-title":"MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3","volume":"25","author":"Wu","year":"2014","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0590","article-title":"MicroRNA-3646 contributes to docetaxel resistance in human breast cancer cells by GSK-3\u03b2\/\u03b2-catenin signaling pathway","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0595","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0600","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12967-019-1932-1","article-title":"Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3\u03b2\/\u03b2-catenin signaling pathway","volume":"17","author":"Dai","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0605","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jmb.2010.07.051","article-title":"The miR-15\/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases","volume":"402","author":"Finnerty","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0610","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/modpathol.2008.135","article-title":"Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma","volume":"22","author":"Flavin","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0615","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1073\/pnas.0508889103","article-title":"microRNAs exhibit high frequency genomic alterations in human cancer","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0620","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgt333","article-title":"Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors","volume":"35","author":"Tahiri","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0625","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-4598-12-23","article-title":"MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1","volume":"12","author":"Creevey","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0630","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bbrc.2013.05.010","article-title":"Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer","volume":"435","author":"Zhao","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0635","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/1078-0432.CCR-10-1800","article-title":"Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer","volume":"17","author":"Li","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0640","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/onc.2012.214","article-title":"MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer","volume":"32","author":"Guo","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0645","first-page":"293","article-title":"Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells","volume":"8","author":"Kim","year":"2014","journal-title":"Drug Des. Develop. Ther."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0650","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/bjc.2012.109","article-title":"The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer","volume":"106","author":"Lajer","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0655","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/ERC-13-0098","article-title":"Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma","volume":"20","author":"Caramuta","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0660","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-12-2043","article-title":"Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia","volume":"19","author":"Lionetti","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0665","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.3892\/or.2014.3439","article-title":"MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K\/AKT and MAPK\/ERK pathways in ovarian cancer","volume":"32","author":"Wang","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0670","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1021\/acsnano.5b07522","article-title":"High-density lipoproteins: nature\u2019s multifunctional nanoparticles","volume":"10","author":"Kuai","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0675","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1194\/jlr.R035964","article-title":"HDL and cholesterol: life after the divorce?","volume":"55","author":"Vickers","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0680","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0685","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1039\/C5TB01332A","article-title":"High-density lipoproteins for therapeutic delivery systems","volume":"4","author":"Mutharasan","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0690","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3389\/fphar.2016.00466","article-title":"Targeting the SR-B1 receptor as a gateway for cancer therapy and imaging","volume":"7","author":"Mooberry","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0695","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fphar.2016.00326","article-title":"Targeting SR-BI for cancer diagnostics, imaging and therapy","volume":"7","author":"Rajora","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0700","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1593\/neo.101372","article-title":"Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles","volume":"13","author":"Shahzad","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0705","first-page":"6095","article-title":"Identifying and targeting angiogenesis-related microRNAs in ovarian cancer","volume":"38","author":"Chen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0710","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.1073\/pnas.1305472110","article-title":"A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis","volume":"110","author":"Vecchione","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0725","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/ijms18061207","article-title":"The functions of microRNA-200 family in ovarian cancer: beyond epithelial-mesenchymal transition","volume":"18","author":"Choi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0730","series-title":"MicroRNA and Cancer","first-page":"179","article-title":"Angiogenesis analysis by in vitro coculture assays in transwell chambers in ovarian cancer","author":"Flores-P\u00e9rez","year":"2018"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0735","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1038\/s41388-019-0862-y","article-title":"Identifying and targeting angiogenesis-related microRNAs in ovarian cancer","volume":"38","author":"Chen","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0740","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1261\/rna.059592.116","article-title":"MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of VE-cadherin expression","volume":"23","author":"Liu","year":"2017","journal-title":"Rna"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-30978-6","article-title":"Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition","volume":"8","author":"Qiu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0750","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.3390\/ijms20215322","article-title":"Interplay between microRNAs and oxidative stress in ovarian conditions with a focus on ovarian cancer and endometriosis","volume":"20","author":"Mar\u00ed-Alexandre","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0755","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2016.11.017","article-title":"MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3","volume":"386","author":"Jeong","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0760","article-title":"Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0765","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fonc.2019.00381","article-title":"HypoxamiRs profiling identify miR-765 as a regulator of the early stages of vasculogenic mimicry in SKOV3 ovarian cancer cells","volume":"9","author":"Salinas-Vera","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0770","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3892\/ijo.2012.1743","article-title":"The microRNA-27a: ZBTB10-specificity protein pathway is involved in follicle stimulating hormone-induced VEGF, Cox2 and survivin expression in ovarian epithelial cancer cells","volume":"42","author":"Lai","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0775","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2014.03.564","article-title":"MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer","volume":"133","author":"Chan","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0780","first-page":"1","article-title":"microRNA-141-3p-containing small extracellular vesicles derived from epithelial ovarian cancer cells promote endothelial cell angiogenesis through activating the JAK\/STAT3 and NF-\u03baB signaling pathways","author":"Masoumi-Dehghi","year":"2020","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0785","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2015.04.023","article-title":"PPAR\u03b3 inhibits ovarian cancer cells proliferation through upregulation of miR-125b","volume":"462","author":"Luo","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0790","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/nar\/gkr730","article-title":"MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis","volume":"40","author":"Xu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0795","first-page":"1","article-title":"A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer","volume":"7","author":"Wu","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0800","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.burns.2014.10.012","article-title":"The expression of miR-125b regulates angiogenesis during the recovery of heat-denatured HUVECs","volume":"41","author":"Zhou","year":"2015","journal-title":"Burns"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052397","article-title":"Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT\/mTOR\/Rac1 signaling and actin reorganization","volume":"7","author":"Imam","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0810","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5491\/SHAW.2012.3.3.166","article-title":"Malignant tumors of the female reproductive system","volume":"3","author":"Weiderpass","year":"2012","journal-title":"Saf. Health Work"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0815","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0820","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0825","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1093\/humrep\/des292","article-title":"microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer","volume":"27","author":"Ram\u00f3n","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0830","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-9966-32-11","article-title":"Effects of ectopic HER-2\/neu gene expression on the COX-2\/PGE2\/P450arom signaling pathway in endometrial carcinoma cells: HER-2\/neu gene expression in endometrial carcinoma cells","volume":"32","author":"Li","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0835","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.18632\/oncotarget.2157","article-title":"MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells","volume":"5","author":"Konno","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0840","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/onc.2010.463","article-title":"MicroRNA-101-mediated Akt activation and estrogen-independent growth","volume":"30","author":"Sachdeva","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0845","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1440-1746.2009.05971.x","article-title":"MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion","volume":"25","author":"Li","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0850","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/onc.2009.192","article-title":"MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation","volume":"28","author":"Lee","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0855","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ijrobp.2011.05.031","article-title":"Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level","volume":"81","author":"Chen","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0860","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140642","article-title":"Cyclooxygenase-2, a potential therapeutic target, is regulated by miR-101 in esophageal squamous cell carcinoma","volume":"10","author":"Shao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0865","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1158\/0008-5472.CAN-08-1274","article-title":"Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice","volume":"68","author":"Daikoku","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0870","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11010-018-3313-0","article-title":"MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma","volume":"448","author":"Liu","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0875","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1158\/0008-5472.CAN-15-2580","article-title":"miR-29b mediates NF-\u03baB signaling in KRAS-induced non-small cell lung cancers","volume":"76","author":"Langsch","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0880","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jcb.22630","article-title":"Transcriptional suppression of mir-29b-1\/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB","volume":"110","author":"Mott","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0885","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4149\/neo_2013_050","article-title":"Alteration of the microRNA expression profile in human osteosarcoma cells transfected with APE1 siRNA","volume":"60","author":"Dai","year":"2013","journal-title":"Neoplasma"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0890","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1182\/blood-2009-03-211938","article-title":"MicroRNA 29b functions in acute myeloid leukemia","volume":"114","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0895","first-page":"5701","article-title":"A key role of microRNA-29b in suppression of osteosarcoma cell proliferation and migration via modulation of VEGF","volume":"7","author":"Zhang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0900","article-title":"ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK\/ERK and PI3K\/Akt pathways","volume":"5","author":"Lin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0905","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1159\/000460510","article-title":"MicroRNA-29b inhibits angiogenesis by targeting VEGFA through the MAPK\/ERK and PI3K\/Akt signaling pathways in endometrial carcinoma","volume":"41","author":"Chen","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0910","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1158\/0008-5472.CAN-10-1346","article-title":"MicroRNAs and metastasis: little RNAs go a long way","volume":"70","author":"Dykxhoorn","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0915","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/embor.2010.117","article-title":"The ZEB\/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?","volume":"11","author":"Brabletz","year":"2010","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0920","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4161\/cc.8.14.9201","article-title":"Opening the treasure chest of miR-200s family members","volume":"8","author":"Davalos","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0925","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1074\/jbc.M110.158790","article-title":"miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells","volume":"286","author":"Chan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0930","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molcel.2010.08.013","article-title":"Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells","volume":"39","author":"Iliopoulos","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0935","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/stem.101","article-title":"miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells","volume":"27","author":"Kong","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0940","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.2401","article-title":"Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization","volume":"17","author":"Korpal","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0945","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1541-7786.MCR-10-0497","article-title":"miR-200 inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1\/VEGFR1","volume":"9","author":"Roybal","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0950","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/onc.2010.201","article-title":"miR-200bc\/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a\/141 in breast cancer","volume":"29","author":"Uhlmann","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0955","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/db10-0892","article-title":"miR-200a prevents renal fibrogenesis through repression of TGF-\u03b22 expression","volume":"60","author":"Wang","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0960","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1073\/pnas.1008301107","article-title":"miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor","volume":"107","author":"Renthal","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0965","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002436","article-title":"MicroRNA expression and identification of putative miRNA targets in ovarian cancer","volume":"3","author":"Dahiya","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0970","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1182\/blood-2008-07-163907","article-title":"MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes","volume":"113","author":"Inomata","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ygyno.2021.03.020_bb0975","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/1933719112438448","article-title":"Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKK\u03b2, KLF9, and FBLN5","volume":"19","author":"Panda","year":"2012","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0985","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1159\/000460510","article-title":"MicroRNA-29b inhibits angiogenesis by targeting VEGFA through the MAPK\/ERK and PI3K\/Akt signaling pathways in endometrial carcinoma","volume":"41","author":"Chen","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0990","first-page":"1291","article-title":"MicroRNA-873 inhibits the proliferation and invasion of endometrial cancer cells by directly targeting hepatoma-derived growth factor","volume":"18","author":"Wang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ygyno.2021.03.020_bb0995","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1093\/humrep\/des292","article-title":"microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer","volume":"27","author":"Ramon","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1000","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.amsu.2016.01.091","article-title":"Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer","volume":"7","author":"Djati","year":"2016","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1010","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","article-title":"Mechanisms of long noncoding RNA function in development and disease","volume":"73","author":"Schmitz","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1015","article-title":"lncRNAs in development and disease: from functions to mechanisms","volume":"7","author":"Del\u00e1s","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1020","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cmet.2016.11.016","article-title":"Human pancreatic \u03b2 cell lncRNAs control cell-specific regulatory networks","volume":"25","author":"Akerman","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cmet.2012.08.010","article-title":"Human \u03b2 cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes","volume":"16","author":"Mor\u00e1n","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1030","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.tig.2017.05.004","article-title":"The diversity of long noncoding RNAs and their generation","volume":"33","author":"Wu","year":"2017","journal-title":"Trends Genet."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cell.2014.09.005","article-title":"Biogenesis of circular RNAs","volume":"159","author":"Vicens","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2021.03.020_bb1040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrm.2015.32","article-title":"The biogenesis and emerging roles of circular RNAs","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4161\/rna.23547","article-title":"Paraspeckle formation during the biogenesis of long non-coding RNAs","volume":"10","author":"Naganuma","year":"2013","journal-title":"RNA Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11646\/zootaxa.3976.1.1","article-title":"Systematic review of diplommatinid land snails (Caenogastropoda, Diplommatinidae) endemic to the Palau Islands. (2) taxonomic revision of Hungerfordia species with low axial ribs","volume":"3976","author":"Yamazaki","year":"2015","journal-title":"Zootaxa"},{"key":"10.1016\/j.ygyno.2021.03.020_bb1055","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nsmb.3479","article-title":"Paraspeckles: nuclear nests helping to raise mature miRNAs","volume":"24","author":"Krol","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4939-3378-5_2","article-title":"Cross-linking immunoprecipitation and qPCR (CLIP-qPCR) analysis to map interactions between long noncoding RNAs and RNA-binding proteins","volume":"1402","author":"Yoon","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1065","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1111\/jcmm.13238","article-title":"State of the art technologies to explore long non-coding RNAs in cancer","volume":"21","author":"Salehi","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1070","first-page":"88","article-title":"Discovery of protein-lncRNA interactions by integrating large-scale CLIP-Seq and RNA-Seq datasets","volume":"2","author":"Li","year":"2014","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2011.12.003","article-title":"Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers","volume":"318","author":"Gloss","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1080","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/hmg\/ddm336","article-title":"Long, abundantly expressed non-coding transcripts are altered in cancer","volume":"17","author":"Perez","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080306","article-title":"Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification","volume":"8","author":"Akrami","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.03.020_bb1090","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/IGC.0000000000000413","article-title":"Functions and mechanisms of long noncoding RNAs in ovarian cancer","volume":"25","author":"Ren","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.03.020_bb1095","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.3892\/ijo.2015.2943","article-title":"Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion\/metastasis in serous ovarian cancer","volume":"46","author":"Qiu","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1100","doi-asserted-by":"crossref","first-page":"25381","DOI":"10.18632\/oncotarget.4541","article-title":"A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer","volume":"6","author":"Cheng","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2021.03.020_bb1105","first-page":"769","article-title":"Relationship of XIST expression and responses of ovarian cancer to chemotherapy","volume":"1","author":"Huang","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1110","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1038\/sj.onc.1207008","article-title":"Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression","volume":"22","author":"Rangel","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.03.020_bb1115","first-page":"270","article-title":"Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequences","volume":"3","author":"Mizrahi","year":"2010","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1120","doi-asserted-by":"crossref","first-page":"12956","DOI":"10.1073\/pnas.0906005106","article-title":"Role of human noncoding RNAs in the control of tumorigenesis","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051310","article-title":"Noncoding RNA:RNA regulatory networks in cancer","volume":"19","author":"Chan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1130","first-page":"1745","article-title":"LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway","volume":"23","author":"Zhang","year":"2018","journal-title":"J. B.U.ON."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/OTT.S182657","article-title":"Long noncoding RNA SNHG15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer","volume":"12","author":"Qu","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1140","first-page":"8630","article-title":"Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway","volume":"22","author":"Qiao","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1145","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1038\/s41388-018-0614-4","article-title":"Long noncoding RNA CRCMSL suppresses tumor invasive and metastasis in colorectal carcinoma through nucleocytoplasmic shuttling of HMGB2","volume":"38","author":"Han","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.03.020_bb1150","doi-asserted-by":"crossref","first-page":"11999","DOI":"10.1002\/jcp.27861","article-title":"Long noncoding RNA DGCR5 suppresses gastric cancer progression by acting as a competing endogenous RNA of PTEN and BTG1","volume":"234","author":"Xu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1155","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1002\/jcp.27483","article-title":"LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma","volume":"234","author":"Chen","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1160","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.2147\/OTT.S214689","article-title":"LncRNA-MALAT1 regulates proliferation and apoptosis of ovarian cancer cells by targeting miR-503-5p","volume":"12","author":"Sun","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1165","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13046-019-1356-z","article-title":"LncRNA FLVCR1-AS1 mediates miR-513\/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer","volume":"38","author":"Yan","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1170","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/jcp.29028","article-title":"Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer","volume":"235","author":"Li","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1175","doi-asserted-by":"crossref","first-page":"109460","DOI":"10.1016\/j.biopha.2019.109460","article-title":"LncRNA SCAMP1 regulates ZEB1\/JUN and autophagy to promote pediatric renal cell carcinoma under oxidative stress via miR-429","volume":"120","author":"Shao","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1180","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1111\/jcmm.14362","article-title":"Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p\/LMX1A\/NLRC5 pathway","volume":"23","author":"Zong","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1185","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1089\/dna.2019.5312","article-title":"Long noncoding RNA SCAMP1 targets miR-137\/CXCL12 Axis to boost cell invasion and angiogenesis in ovarian cancer","volume":"39","author":"Song","year":"2020","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1190","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1101\/gad.182121.111","article-title":"Suppression of progenitor differentiation requires the long noncoding RNA ANCR","volume":"26","author":"Kretz","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1195","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/mc.23117","article-title":"LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145","volume":"58","author":"Lin","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1200","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3892\/or.2017.5905","article-title":"Long non-coding RNAs on the stage of cervical cancer (review)","volume":"38","author":"Dong","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.yexmp.2018.11.010","article-title":"Long non-coding RNAs and cervical cancer","volume":"106","author":"Aalijahan","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/humu.20015","article-title":"Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer","volume":"23","author":"Baldinu","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1215","first-page":"235","article-title":"CASC2a gene is down-regulated in endometrial cancer","volume":"27","author":"Baldinu","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cellsig.2014.11.011","article-title":"Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21","volume":"27","author":"Wang","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1225","first-page":"4584","article-title":"Long noncoding RNA CASC2 inhibits metastasis and epithelial to mesenchymal transition of lung adenocarcinoma via suppressing SOX4","volume":"21","author":"Wang","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1230","first-page":"3261","article-title":"Long non-coding RNA cancer susceptibility candidate 2 inhibits the cell proliferation, invasion and angiogenesis of cervical cancer through the MAPK pathway","volume":"23","author":"Wang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1235","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.18632\/oncotarget.6731","article-title":"Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways","volume":"7","author":"Fu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2021.03.020_bb1240","first-page":"5012","article-title":"Long non-coding RNA HOTAIR enhances angiogenesis by induction of VEGFA expression in glioma cells and transmission to endothelial cells via glioma cell derived-extracellular vesicles","volume":"9","author":"Ma","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3892\/ijo.2014.2758","article-title":"Long non-coding RNA HOTAIR is associated with human cervical cancer progression","volume":"46","author":"Kim","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1250","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12253-019-00614-3","article-title":"MEG3: an oncogenic long non-coding RNA in different cancers","volume":"25","author":"Al-Rugeebah","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/bs.acc.2019.12.004","article-title":"Long non-coding RNA HOTAIR in cervical cancer: molecular marker, mechanistic insight, and therapeutic target","volume":"97","author":"Zhou","year":"2020","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1260","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/s41418-018-0242-0","article-title":"A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer","volume":"26","author":"Ding","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1265","first-page":"1296","article-title":"Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3\/miR-421\/PDGFRA axis","volume":"55","author":"Ye","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.020_bb1270","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3233\/HAB-200411","article-title":"LINK-A long non-coding RNA and VEGF RNA expression in epithelial ovarian cancer patients","volume":"28","author":"Maleki","year":"2020","journal-title":"Human Antibodies"},{"key":"10.1016\/j.ygyno.2021.03.020_bb1275","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/CAD.0000000000000734","article-title":"Knockdown of long noncoding RNA-taurine-upregulated gene 1 inhibits tumor angiogenesis in ovarian cancer by regulating leucine-rich \u03b1-2-glycoprotein-1","volume":"30","author":"Fan","year":"2019","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.ygyno.2021.03.020_bb1280","doi-asserted-by":"crossref","first-page":"12047","DOI":"10.1096\/fj.201900101RR","article-title":"Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-\u03baB1","volume":"33","author":"Ruan","year":"2019","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.ygyno.2021.03.020_bb1285","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1089\/dna.2019.5312","article-title":"Long Noncoding RNA SCAMP1 Targets miR-137\/CXCL12 Axis to Boost Cell Invasion and Angiogenesis in Ovarian Cancer","volume":"39","author":"Song","year":"2020","journal-title":"DNA Cell Biol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821002584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821002584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:50:40Z","timestamp":1715820640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821002584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":249,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0090825821002584"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.03.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs related to angiogenesis in gynecological cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}